The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDiploma Regulatory News (DPLM)

Share Price Information for Diploma (DPLM)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 3,816.00
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 4.00 (0.105%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 3,816.00
DPLM Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Statement

17 Mar 2009 07:00

RNS Number : 9511O
Diploma PLC
17 March 2009
 



 

12 CHARTERHOUSE SQUARE, LONDON EC1M 6AXTELEPHONE: +44 (0)20 7549 5700FACSIMILE: +44 (0)20 7549 5715

FOR IMMEDIATE RELEASE

17 March 2009

DIPLOMA PLC

TRADING UPDATE

Diploma PLC, the international group of businesses supplying specialised technical products and services, is today issuing a trading update, ahead of going into close period at 31 March 2009.

The Group's performance during the first half of the year has been impacted by a weakening in the general trading environment across all sectors and particularly in the Seals businesses in North America. At the same time, the continued weakness of UK sterling, relative to all other major currencies, has had a strong positive impact on the Group's results from translation of the results of the overseas businesses.

Against this background, the Group expects reported revenue for the six months ended 31 March 2009 to be a little ahead of the comparable period last year and, on a constant currency basis, down approximately 8-10%.

Operating profits have benefited from currency translation, as well as from the initial contribution of RT Dygert, acquired in January 2009. On a transaction basis, however, currency effects have had a negative effect on gross margins, particularly in the UK and Canadian businesses. Combined with pressures from the generally weaker trading conditions, reported operating profits are likely to be 5-7% below the comparable period last year.

In Life Sciences, the Canadian businesses have continued to make progress in markets where overall funding remains steady, but increased focus is being placed by customers on cost efficiency. The European businesses have experienced some reduction in revenues and have responded by reducing their cost base.

In Seals, the weaker trading conditions seen in the broader US industrial markets towards the end of 2008 have continued and similar effects are now being seen in the European and other international markets. While the Aftermarket businesses have shown some resilience, there has been a more marked slowdown in those businesses supplying to industrial OEMs and construction equipment dealers. Cost reduction programmes have been, and continue to be, implemented across the Seals businesses, but these inevitably lag the revenue reduction and will not fully offset the negative impact from operational leverage.

The Controls businesses have mostly proved to be more buoyant than the general economies in which they operate, due to their focus on technically driven markets. However, some softening in UK revenues has been seen in recent months, particularly in those businesses more exposed to manufacturing markets. Similarly, weaker trading activity is now being experienced in Germany, particularly with those customers who are dependent on export markets. Again cost reduction programmes are being implemented to help mitigate the impact from reducing revenues.

The Group's businesses have responded well in taking action to reduce working capital in response to the reduction in revenues and the Group continues to maintain a strong financial position. After the payment in January 2009 of both the final dividend of 5.0p (£5.6m) and the initial consideration of US$14.4m (£9.5m) for RT/Dygert, the Group will have positive net cash funds at 31 March 2009. Strong operating cash flow is expected in the second half of the year and the Group also maintains committed bank facilities of £20.0m. The ungeared balance sheet and strong cash flow provides a secure platform to support the continued development of the Group.

The Directors will provide an update on trading prospects for the year on Monday, 11 May 2009, as part of their announcement of the Group's results for the six months ended 31 March 2009. 

For further enquiries please contact:

Bruce Thompson, Chief Executive Officer

020 7549 5700

Nigel Lingwood, Group Finance Director

020 7549 5705

Simon Bloomfield, Bankside Consultants

020 7367 8861

NOTE TO EDITORS:

Diploma PLC is an international group of businesses supplying specialised technical products and services to the Life Sciences, Seals and Controls industries.

Diploma achieves stable growth and attractive margins from its focus on supplying specialised technical products to markets which value high levels of customer service, technical support and value adding activities. A high proportion of revenues are generated from essential products and services funded by operating, rather than capital budgets.

The Group employs ca. 1,000 employees and its principal operating businesses are located in the UKGermany, US and Canada.

In the last five years ended 30 September 2008, the Group has grown adjusted earnings per share at an average of ca. 21% p.a. through a combination of organic growth and acquisitions. The current market capitalisation is ca. £110m.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTGUUQCWUPBGMQ
Date   Source Headline
2nd May 20247:00 amRNSAcquisition
25th Apr 20243:54 pmRNSHolding(s) in Company
3rd Apr 20247:00 amRNSHolding(s) in Company
27th Mar 20247:00 amRNSAcquisition
5th Mar 20242:07 pmRNSHolding(s) in Company
17th Jan 20243:21 pmRNSResult of AGM
17th Jan 20247:00 amRNSQ1 trading update
20th Dec 20237:00 amRNSAppointment of Non-Executive Director
18th Dec 20237:00 amRNSDirector/PDMR Shareholding
14th Dec 202311:31 amRNSHolding(s) in Company
11th Dec 20237:00 amRNSAnnual Financial Report & Notice of AGM
5th Dec 20233:00 pmRNSDirector/PDMR Shareholding
1st Dec 20237:00 amRNSTotal Voting Rights
28th Nov 20237:00 amRNSDirector/PDMR Grant of LTIP Awards
21st Nov 20237:00 amRNSDirector/PDMR Shareholding
20th Nov 20237:00 amRNSFull Year Results
16th Nov 20237:00 amRNSIssue of Shares & Total Voting Rights
10th Oct 202312:29 pmRNSHolding(s) in Company
21st Aug 202310:10 amRNSHolding(s) in Company
15th Aug 20233:54 pmRNSHolding(s) in Company
18th Jul 20237:00 amRNSDirector/PDMR Shareholding
13th Jul 20237:00 amRNSStrategic acquisition in European Fluid Power
13th Jul 20237:00 amRNSQ3 Trading Update
27th Jun 20237:00 amRNSCapital Markets Seminar
13th Jun 20235:09 pmRNSHolding(s) in Company
7th Jun 20233:49 pmRNSHolding(s) in Company
30th May 20237:00 amRNSAppointment of Non-Executive Director
22nd May 20233:30 pmRNSHolding(s) in Company
15th May 20237:00 amRNSHalf-year Report
3rd Apr 20237:00 amRNSTotal Voting Rights
27th Mar 202310:34 amRNSHolding(s) in Company
24th Mar 20234:00 pmRNSDirector/PDMR Shareholding
23rd Mar 20232:34 pmRNSHolding(s) in Company
22nd Mar 20237:00 amRNSIssue of Shares and Total Voting Rights
22nd Mar 20237:00 amRNSDirector/PDMR Shareholding
20th Mar 20239:14 amRNSHolding(s) in Company
17th Mar 20236:00 pmRNSDiploma
17th Mar 20237:00 amRNSResult of Placing
16th Mar 20234:47 pmRNSRetail Offer
16th Mar 20234:46 pmRNSProposed Placing
16th Mar 20234:45 pmRNSAcquisition and M&A Pipeline Update
20th Feb 20239:35 amRNSHolding(s) in Company
9th Feb 20238:27 amRNSHolding(s) in Company
30th Jan 20232:53 pmRNSHolding(s) in Company
19th Jan 20237:00 amRNSDirector/PDMR Grant of LTIP Award
18th Jan 202311:13 amRNSResult of AGM
18th Jan 20237:00 amRNSTrading Statement
12th Dec 20227:00 amRNSAnnual Financial Report & Notice of AGM
9th Dec 202210:33 amRNSHolding(s) in Company - Replacement
8th Dec 20229:41 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.